Originally I had hoped they might do a little better, but given the recent weakness this was a much better quarter than I might have feared. Backlog as you note is very impressive. Margins aren’t holding up badly, and there was somewhat higher R&D spend which if you are going to spend is where I would rather see it.
Should be a good day with the stock up over a dollar pre-market on minimal volume.
News 
Market Data 
Discover 
